Phase 3 Readout~month

Phase 3 Topline: A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Investigate the Efficacy and Safety

Indication
Metastatic Non-Small Cell Lung Cancer; Advanced Non-Small Cell Lung Cancer; EGFR Exon 20 Mutations

Other upcoming events for AVBP

Phase 3 ReadoutPhase 3 Topline: A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Investigate the Efficacy and Safety — AVBP Phase 3 Readout | BioSniper